Literature DB >> 10952057

Extensive injury of descending neurons demonstrated by retrograde labeling in a virus-induced murine model of chronic inflammatory demyelination.

D Ure1, M Rodriguez.   

Abstract

Persistent Theiler's virus infection of SJL/J mice was used as a model to quantitatively assess the extent of descending neuron injury by chronic inflammatory demyelination of the spinal cord. By 9 months postinfection, inflammatory demyelinating lesions were present throughout the spinal cord, affecting up to 31% of the cross-sectional area of the ventrolateral columns. Axon dropout was evident in the lesions by electron microscopy and by quantitation of axons in normal-appearing white matter. Axon number in the ventrolateral columns at L1/L2 was reduced by 23% and total axon area was reduced by 37%, compared with uninfected mice. The most informative data on descending neuron injury, however, was a reduction in retrograde. Fluoro-Gold labeling. Labeling from T11/T12 of rubrospinal, reticulospinal/raphespinal, and vestibulospinal neurons was reduced by 60%, 70%, and 93%, respectively. Retrograde responses to axonal injury were observed, consisting of atrophied cell bodies, indented nuclei, and abundant lipofuscin, but cell body dropout was minimal. The number of cell bodies of vestibulospinal neurons was reduced by only 35%, whereas the number of cell bodies of rubrospinal neurons was unchanged. These results demonstrate that chronic inflammatory demyelination can severely injure axons and emphasize the need to design neuroprotective therapies in human multiple sclerosis.

Entities:  

Mesh:

Year:  2000        PMID: 10952057     DOI: 10.1093/jnen/59.8.664

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  9 in total

1.  Absence of perforin expression confers axonal protection despite demyelination.

Authors:  Charles L Howe; Jaimie D Adelson; Moses Rodriguez
Journal:  Neurobiol Dis       Date:  2006-11-16       Impact factor: 5.996

2.  Deletion of beta-2-microglobulin ameliorates spinal cord lesion load and promotes recovery of brainstem NAA levels in a murine model of multiple sclerosis.

Authors:  Aleksandar Denic; Istvan Pirko; Bharath Wootla; Allan Bieber; Slobodan Macura; Moses Rodriguez
Journal:  Brain Pathol       Date:  2012-03-08       Impact factor: 6.508

3.  Brainstem 1H nuclear magnetic resonance (NMR) spectroscopy: marker of demyelination and repair in spinal cord.

Authors:  Aleksandar Denic; Allan Bieber; Arthur Warrington; Prasanna K Mishra; Slobodan Macura; Moses Rodriguez
Journal:  Ann Neurol       Date:  2009-10       Impact factor: 10.422

4.  Virus-mediated autoimmunity in Multiple Sclerosis.

Authors:  Nikolaos Grigoriadis; Georgios M Hadjigeorgiou
Journal:  J Autoimmune Dis       Date:  2006-02-19

5.  A single dose of a neuron-binding human monoclonal antibody improves brainstem NAA concentrations, a biomarker for density of spinal cord axons, in a model of progressive multiple sclerosis.

Authors:  Bharath Wootla; Aleksandar Denic; Jens O Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  J Neuroinflammation       Date:  2015-04-29       Impact factor: 8.322

Review 6.  Viral induced demyelination.

Authors:  S A Stohlman; D R Hinton
Journal:  Brain Pathol       Date:  2001-01       Impact factor: 6.508

7.  A monoclonal natural human IgM protects axons in the absence of remyelination.

Authors:  Bharath Wootla; Aleksandar Denic; Arthur E Warrington; Moses Rodriguez
Journal:  J Neuroinflammation       Date:  2016-04-28       Impact factor: 8.322

Review 8.  Antibody-Mediated Oligodendrocyte Remyelination Promotes Axon Health in Progressive Demyelinating Disease.

Authors:  Bharath Wootla; Aleksandar Denic; Jens O Watzlawik; Arthur E Warrington; Moses Rodriguez
Journal:  Mol Neurobiol       Date:  2015-09-26       Impact factor: 5.590

9.  Aging and neuroinflammation: Changes in immune cell responses, axon integrity, and motor function in a viral model of progressive multiple sclerosis.

Authors:  Leyre Mestre; Graciela Alonso; Ana Feliú; Miriam Mecha; Carolina Martín; Luisa M Villar; Carmen Guaza
Journal:  Aging Cell       Date:  2021-08-06       Impact factor: 9.304

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.